|
US1001159A
(en)
|
1910-07-25 |
1911-08-22 |
Elizabeth Nielsen |
Skirt-gage.
|
|
GB1472257A
(en)
|
1973-09-10 |
1977-05-04 |
Christiaens Sa A |
Derivative of 4-hydroxy-5-azacoumarin
|
|
US4866182A
(en)
|
1988-02-18 |
1989-09-12 |
Merrell Dow Pharmaceuticals Inc. |
Cardiotonic alkanoyl and aroyl oxazolones
|
|
US5338740A
(en)
|
1993-07-13 |
1994-08-16 |
Pfizer Inc. |
Angiotensin II receptor antagonists
|
|
JP3795305B2
(ja)
|
1999-07-19 |
2006-07-12 |
田辺製薬株式会社 |
医薬組成物
|
|
MXPA03007513A
(es)
|
2001-02-21 |
2004-07-30 |
Nps Pharma Inc |
Compuestos heteropoliciclicos y su uso como antagonistas del receptor metabotropico de glutamato.
|
|
IL157009A0
(en)
|
2001-03-28 |
2004-02-08 |
Pfizer |
N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad
|
|
CA2459224C
(en)
|
2001-09-03 |
2012-05-08 |
Takeda Chemical Industries, Ltd. |
1,3-benzothiazinone derivatives and the use thereof
|
|
JP2005162612A
(ja)
|
2002-01-09 |
2005-06-23 |
Ajinomoto Co Inc |
アシルスルホンアミド誘導体
|
|
JP2005170790A
(ja)
|
2002-01-09 |
2005-06-30 |
Ajinomoto Co Inc |
Ｎ−アルキルスルフォニル置換アミド誘導体
|
|
ATE448784T1
(de)
*
|
2002-02-14 |
2009-12-15 |
Pharmacia Corp |
Substituierte pyridinone als modulatoren für p38 map kinase
|
|
US20040147561A1
(en)
*
|
2002-12-27 |
2004-07-29 |
Wenge Zhong |
Pyrid-2-one derivatives and methods of use
|
|
WO2005004818A2
(en)
|
2003-07-09 |
2005-01-20 |
Imclone Systems Incorporated |
Heterocyclic compounds and their use as anticancer agents
|
|
US20060004001A1
(en)
|
2004-02-27 |
2006-01-05 |
Merz Pharma Gmbh & Co., Kgaa |
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
|
|
PE20060285A1
(es)
*
|
2004-03-30 |
2006-05-08 |
Aventis Pharma Inc |
Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
|
|
BRPI0509298A
(pt)
|
2004-04-01 |
2007-09-18 |
Lilly Co Eli |
composto, composição farmacêutica, métodos de inibir receptor h3 de histamina em um mamìfero, para tratar ou prevenir um distúrbio do sistema nervoso, obesidade, e um distúrbio ou doença, e, uso de um composto
|
|
KR101195801B1
(ko)
|
2004-06-18 |
2012-11-05 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
Ｘａ 인자 억제제
|
|
CA2575081C
(en)
|
2004-07-26 |
2013-05-07 |
Eli Lilly And Company |
Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses
|
|
EP1655283A1
(en)
|
2004-11-08 |
2006-05-10 |
Evotec OAI AG |
11beta-HSD1 Inhibitors
|
|
EP2049497A2
(en)
*
|
2005-05-19 |
2009-04-22 |
Astex Therapeutics Limited |
Pyrimidine derivatives as hsp90 inhibitors
|
|
WO2007023242A1
(en)
|
2005-08-24 |
2007-03-01 |
Merz Pharma Gmbh & Co. Kgaa |
Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
|
|
DK1984353T3
(en)
|
2006-01-23 |
2016-03-14 |
Amgen Inc |
Aurorakinasemodulatorer and method of use
|
|
JP2007314516A
(ja)
|
2006-04-25 |
2007-12-06 |
Daiichi Sankyo Co Ltd |
２以上の置換基を有するベンゼン化合物を含有する医薬
|
|
KR101403887B1
(ko)
|
2006-08-03 |
2014-06-20 |
트러스티즈 오브 터프츠 칼리지 |
홍조화를 유발하지 않는 니아신 유사체, 및 이의 사용 방법
|
|
JP2009545630A
(ja)
|
2006-08-04 |
2009-12-24 |
プリーシス・ファーマシューティカルズ・インコーポレイテッド |
化合物
|
|
EP1894924A1
(en)
|
2006-08-29 |
2008-03-05 |
Phenex Pharmaceuticals AG |
Heterocyclic FXR binding compounds
|
|
CA2670491A1
(en)
|
2006-12-01 |
2008-06-12 |
Novartis Ag |
Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy
|
|
EP2144911A2
(en)
|
2007-03-28 |
2010-01-20 |
NeuroSearch AS |
Purinyl derivatives and their use as potassium channel modulators
|
|
JP2011504505A
(ja)
*
|
2007-11-21 |
2011-02-10 |
デコード ジェネティクス イーエイチエフ |
肺および心血管障害を治療するためのビアリールｐｄｅ４抑制剤
|
|
EP2254563A2
(en)
|
2008-01-25 |
2010-12-01 |
Torrent Pharmaceuticals Ltd. |
Pharmaceutical combinations comprising specified age breaker and further drugs, i.a. antihypertensive drugs, antidiabetic drugs etc
|
|
CA2721060A1
(en)
|
2008-04-09 |
2009-10-15 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
EP2304366A2
(en)
|
2008-05-30 |
2011-04-06 |
Foster Wheeler Energia Oy |
Method of and system for generating power by oxyfuel combustion
|
|
US8124649B2
(en)
|
2008-06-30 |
2012-02-28 |
Cylene Pharmaceuticals, Inc. |
Oxindole compounds
|
|
WO2010050445A1
(ja)
|
2008-10-27 |
2010-05-06 |
武田薬品工業株式会社 |
二環性化合物
|
|
WO2010053545A2
(en)
*
|
2008-11-04 |
2010-05-14 |
Anchor Therapeutics, Inc. |
Apj receptor compounds
|
|
JP2013505912A
(ja)
|
2009-09-24 |
2013-02-21 |
エフ．ホフマン−ラ ロシュ アーゲー |
複素環式抗ウイルス化合物
|
|
BR112012006630A2
(pt)
|
2009-09-24 |
2016-05-03 |
Hoffmann La Roche |
derivados em indol como moduladores dos canais de cálcio ativados para liberação de cálcio (crac)
|
|
US8609663B2
(en)
|
2009-11-18 |
2013-12-17 |
University Of Massachusetts |
Compounds for modulating TLR2
|
|
AU2010330743A1
(en)
|
2009-12-18 |
2012-07-05 |
Activesite Pharmaceuticals, Inc. |
Prodrugs of inhibitors of plasma kallikrein
|
|
CN102241621A
(zh)
|
2010-05-11 |
2011-11-16 |
江苏恒瑞医药股份有限公司 |
5,5-双取代-2-亚氨基吡咯烷类衍生物、其制备方法及其在医药上的应用
|
|
JP5892550B2
(ja)
|
2010-05-24 |
2016-03-23 |
トーアエイヨー株式会社 |
縮合イミダゾール誘導体
|
|
EP2619190B1
(en)
*
|
2010-09-24 |
2015-08-12 |
Bristol-Myers Squibb Company |
Substituted oxadiazole compounds and their use as s1p1 agonists
|
|
WO2012074022A1
(ja)
|
2010-12-01 |
2012-06-07 |
旭硝子株式会社 |
イリジウムカチオン錯体および発光組成物
|
|
WO2012117097A1
(en)
|
2011-03-03 |
2012-09-07 |
Universität des Saarlandes |
Biaryl derivatives as selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors
|
|
WO2012142308A1
(en)
|
2011-04-13 |
2012-10-18 |
Activesite Pharmaceuticals, Inc. |
Prodrugs of inhibitors of plasma kallikrein
|
|
JP6130827B2
(ja)
|
2011-05-17 |
2017-05-17 |
塩野義製薬株式会社 |
ヘテロ環化合物
|
|
WO2013092943A1
(en)
|
2011-12-23 |
2013-06-27 |
Basf Se |
Isothiazoline compounds for combating invertebrate pests
|
|
CA2871270A1
(en)
*
|
2012-05-02 |
2013-11-07 |
Lupin Limited |
Substituted pyridine compounds as crac modulators
|
|
WO2013167633A1
(en)
|
2012-05-09 |
2013-11-14 |
Basf Se |
Acrylamide compounds for combating invertebrate pests
|
|
WO2013184202A1
(en)
|
2012-06-08 |
2013-12-12 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Fbxo3 inhibitors
|
|
WO2014006045A1
(en)
|
2012-07-02 |
2014-01-09 |
Max-Delbrück-Centrum für Molekulare Medizin |
Psoralen derivatives for preventing or treating heart failure or cardiac hypertrophy
|
|
CN103570625A
(zh)
|
2012-07-19 |
2014-02-12 |
南京英派药业有限公司 |
N-(3-杂芳基芳基)-4-芳基芳基甲酰胺和类似物作为Hedgehog通路抑制剂及其应用
|
|
WO2014031928A2
(en)
|
2012-08-24 |
2014-02-27 |
Philip Jones |
Heterocyclic modulators of hif activity for treatment of disease
|
|
WO2014044738A1
(en)
*
|
2012-09-21 |
2014-03-27 |
Sanofi |
Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators
|
|
WO2014062938A1
(en)
|
2012-10-19 |
2014-04-24 |
Bristol-Myers Squibb Company |
Rory modulators
|
|
EP2972394A4
(en)
|
2013-03-15 |
2016-11-02 |
Sloan Kettering Inst Cancer |
HSP90-DESIGNING AND THERAPY
|
|
WO2015017305A1
(en)
|
2013-07-31 |
2015-02-05 |
Merck Sharp & Dohme Corp |
Inhibitors of the renal outer medullary potassium channel
|
|
JP6199197B2
(ja)
|
2014-02-07 |
2017-09-20 |
花王株式会社 |
ポリオキシアルキレンアルキルエーテルカルボン酸塩の製造方法
|
|
JP2017071553A
(ja)
|
2014-02-25 |
2017-04-13 |
味の素株式会社 |
ヘテロ原子−メチレン−ヘテロ環構造を有する新規化合物
|
|
MX2016012175A
(es)
|
2014-03-20 |
2017-01-19 |
Bayer Pharma AG |
Nuevos compuestos.
|
|
WO2015191630A1
(en)
|
2014-06-10 |
2015-12-17 |
Sanford-Burnham Medical Research Institute |
Metabotropic glutamate receptor negative allosteric modulators (nams) and uses thereof
|
|
HUE050317T2
(hu)
|
2015-05-20 |
2020-11-30 |
Amgen Inc |
APJ receptor triazol agonistái
|
|
PL3303330T3
(pl)
*
|
2015-06-03 |
2019-10-31 |
Bristol Myers Squibb Co |
Agoniści 4 - hydroksy - 3 - ( heteroarylo ) pirydyno - 2 - onowi receptora apj do stosowania w leczeniu zaburzeń sercowo-naczyniowych
|
|
KR101711744B1
(ko)
|
2015-07-16 |
2017-03-02 |
경희대학교 산학협력단 |
옥사디아졸 유도체, 이의 제조방법 및 이를 포함하는 전자수송층
|
|
CA3001974A1
(en)
|
2015-10-14 |
2017-04-20 |
Bristol-Myers Squibb Company |
2,4-dihydroxy-nicotinamides as apj agonists
|
|
EP3380970B1
(en)
|
2015-11-24 |
2023-01-04 |
Sanford Burnham Prebys Medical Discovery Institute |
Novel azole derivatives as apelin receptor agonist
|
|
EP3383860B1
(en)
|
2015-12-04 |
2021-01-20 |
Bristol-Myers Squibb Company |
Apelin receptor agonists and methods of use
|
|
WO2017100558A1
(en)
|
2015-12-09 |
2017-06-15 |
Research Triangle Institute |
Improved apelin receptor (apj) agonists and uses thereof
|
|
TW201725203A
(zh)
|
2015-12-16 |
2017-07-16 |
必治妥美雅史谷比公司 |
作為ａｐｊ受體促效劑之雜芳基羥基嘧啶酮
|
|
SG11201808163WA
(en)
|
2016-03-24 |
2018-10-30 |
Bristol Myers Squibb Co |
6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists
|
|
ES2844184T3
(es)
|
2016-06-14 |
2021-07-21 |
Bristol Myers Squibb Co |
4-hidroxi-3-sulfonilpiridin-2(1H)-onas como agonistas del receptor de APJ
|
|
US10508104B2
(en)
|
2016-06-14 |
2019-12-17 |
Bristol-Myers Squibb Company |
6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonists
|
|
CN110072850B
(zh)
|
2016-10-14 |
2023-07-21 |
百时美施贵宝公司 |
3-磺酰基-5-氨基吡啶-2,4-二醇apj激动剂
|